ELI LILLY & Co (LLY) Gross Profit (2009 - 2026)
Eli Lilly's (LLY) quarterly Gross Profit came in at $16.2 billion in Q1 2026, up 54.44% YoY from $10.5 billion in Q1 2025, and up 1.9% on a QoQ basis from $15.9 billion in Q4 2025.
ELI LILLY & Co (LLY) Gross Profit (2009 - 2026) Analysis & Trends
Eli Lilly (LLY) has 18 years of Gross Profit data on file, last reported at $16.2 billion in Q1 2026.
- Quarterly Gross Profit rose 54.44% year-over-year to $16.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.8 billion (up 49.48% YoY) and the FY2025 annual result came in at $54.1 billion, up 47.79% from the prior year.
- Gross Profit grew to $16.2 billion in Q1 2026, from $15.9 billion in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $16.2 billion in Q1 2026 to a low of $5.1 billion in Q2 2022.
- A 5-year average of $9.2 billion and a median of $7.6 billion in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit dropped 7.05% — and 2025, when it soared 57.45%.
- Tracing LLY's Gross Profit over 5 years: stood at $5.8 billion in 2022, then soared by 31.49% to $7.6 billion in 2023, then surged by 47.11% to $11.1 billion in 2024, then surged by 43.04% to $15.9 billion in 2025, then rose by 1.9% to $16.2 billion in 2026.
- The last three Gross Profit figures came in at $16.2 billion (Q1 2026), $15.9 billion (Q4 2025), and $14.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|